Williams KJ - Search Results

1

Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques.

Frias JC, Williams KJ, Fisher EA, Fayad ZA. Frias JC, et al. Among authors: williams kj. J Am Chem Soc. 2004 Dec 22;126(50):16316-7. doi: 10.1021/ja044911a. J Am Chem Soc. 2004. PMID: 15600321

2

Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging.

Frias JC, Ma Y, Williams KJ, Fayad ZA, Fisher EA. Frias JC, et al. Among authors: williams kj. Nano Lett. 2006 Oct;6(10):2220-4. doi: 10.1021/nl061498r. Nano Lett. 2006. PMID: 17034087

3

HDL as a contrast agent for medical imaging.

Cormode DP, Frias JC, Ma Y, Chen W, Skajaa T, Briley-Saebo K, Barazza A, Williams KJ, Mulder WJ, Fayad ZA, Fisher EA. Cormode DP, et al. Among authors: williams kj. Clin Lipidol. 2009 Aug;4(4):493-500. doi: 10.2217/clp.09.38. Clin Lipidol. 2009. PMID: 20352038 Free PMC article.

4

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. Pan M, et al. Among authors: williams kj. J Clin Invest. 2004 May;113(9):1277-87. doi: 10.1172/JCI19197. J Clin Invest. 2004. PMID: 15124019 Free PMC article.

5

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.

Robinson JG, Williams KJ, Gidding S, Borén J, Tabas I, Fisher EA, Packard C, Pencina M, Fayad ZA, Mani V, Rye KA, Nordestgaard BG, Tybjærg-Hansen A, Douglas PS, Nicholls SJ, Pagidipati N, Sniderman A. Robinson JG, et al. Among authors: williams kj. J Am Heart Assoc. 2018 Oct 16;7(20):e009778. doi: 10.1161/JAHA.118.009778. J Am Heart Assoc. 2018. PMID: 30371276 Free PMC article. Review. No abstract available.

6

Cellular and molecular mechanisms for rapid regression of atherosclerosis: from bench top to potentially achievable clinical goal.

Williams KJ, Feig JE, Fisher EA. Williams KJ, et al. Curr Opin Lipidol. 2007 Aug;18(4):443-50. doi: 10.1097/MOL.0b013e32823bcb15. Curr Opin Lipidol. 2007. PMID: 17620862 Review.

7

The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways.

Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, Sparks JD, Williams KJ. Fisher EA, et al. Among authors: williams kj. J Biol Chem. 2001 Jul 27;276(30):27855-63. doi: 10.1074/jbc.M008885200. Epub 2001 Apr 2. J Biol Chem. 2001. PMID: 11285257 Free article.

8

Autophagy of an oxidized, aggregated protein beyond the ER: a pathway for remarkably late-stage quality control.

Fisher EA, Williams KJ. Fisher EA, et al. Among authors: williams kj. Autophagy. 2008 Jul;4(5):721-3. doi: 10.4161/auto.6346. Epub 2008 May 27. Autophagy. 2008. PMID: 18560269

9

How an artery heals.

Williams KJ, Tabas I, Fisher EA. Williams KJ, et al. Circ Res. 2015 Nov 6;117(11):909-13. doi: 10.1161/CIRCRESAHA.115.307609. Circ Res. 2015. PMID: 26541678 Free PMC article. No abstract available.

10

Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory?

Williams KJ, Fisher EA. Williams KJ, et al. Curr Opin Clin Nutr Metab Care. 2005 Mar;8(2):139-46. doi: 10.1097/00075197-200503000-00006. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15716791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

647 results

Search Page

Filters